11239 related articles for article (PubMed ID: 1428001)
1. Analysis of clonality of tumour infiltrating lymphocytes in breast cancer and uveal melanoma.
Durie FH; George WD; Campbell AM; Damato BE
Immunol Lett; 1992 Aug; 33(3):263-9. PubMed ID: 1428001
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
3. An analysis of T-cell-receptor variable-region genes in tumor-infiltrating lymphocytes within malignant tumors.
Nitta T; Sato K; Okumura K; Steinman L
Int J Cancer; 1991 Oct; 49(4):545-50. PubMed ID: 1655662
[TBL] [Abstract][Full Text] [Related]
4. Predominant expression of T cell receptor V alpha 7 in tumor-infiltrating lymphocytes of uveal melanoma.
Nitta T; Oksenberg JR; Rao NA; Steinman L
Science; 1990 Aug; 249(4969):672-4. PubMed ID: 2382141
[TBL] [Abstract][Full Text] [Related]
5. Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes.
Filgueira L; Zuber M; Merlo A; Harder F; Heberer M; Spagnoli GC
Eur J Cancer; 1993; 29A(12):1754-60. PubMed ID: 8398305
[TBL] [Abstract][Full Text] [Related]
6. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
7. Analysis of lymphocytic infiltration in uveal melanoma.
Durie FH; Campbell AM; Lee WR; Damato BE
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2106-10. PubMed ID: 2211008
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
9. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.
Whitford P; Mallon EA; George WD; Campbell AM
Br J Cancer; 1990 Dec; 62(6):971-5. PubMed ID: 2124138
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor gene rearrangements and cytotoxic activities of clones isolated from tumour-infiltrating lymphocytes (TIL) from melanoma patients.
Pandolfi F; Boyle LA; Trentin L; Oliva A; Kurnick JT
Clin Exp Immunol; 1994 Jan; 95(1):141-7. PubMed ID: 8287599
[TBL] [Abstract][Full Text] [Related]
12. Usage of T-cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma.
Weidmann E; Elder EM; Trucco M; Lotze MT; Whiteside TL
Int J Cancer; 1993 May; 54(3):383-90. PubMed ID: 8509212
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
Krishna Y; McCarthy C; Kalirai H; Coupland SE
Hum Pathol; 2017 Aug; 66():159-166. PubMed ID: 28655639
[TBL] [Abstract][Full Text] [Related]
14. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
[TBL] [Abstract][Full Text] [Related]
15. Characterization of T-cell receptor V beta repertoire in ovarian tumour-reacting CD3+ CD8+ CD4- CTL lines.
Fisk B; Flytzanis CN; Pollack MS; Wharton JT; Ioannides CG
Scand J Immunol; 1994 Dec; 40(6):591-600. PubMed ID: 7848491
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
Beguinot M; Dauplat MM; Kwiatkowski F; Lebouedec G; Tixier L; Pomel C; Penault-Llorca F; Radosevic-Robin N
BMC Cancer; 2018 Feb; 18(1):129. PubMed ID: 29394917
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma.
Whelchel JC; Farah SE; McLean IW; Burnier MN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2603-6. PubMed ID: 8325762
[TBL] [Abstract][Full Text] [Related]
18. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
19. High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.
Emerson RO; Sherwood AM; Rieder MJ; Guenthoer J; Williamson DW; Carlson CS; Drescher CW; Tewari M; Bielas JH; Robins HS
J Pathol; 2013 Dec; 231(4):433-440. PubMed ID: 24027095
[TBL] [Abstract][Full Text] [Related]
20. Deep Sequencing of T-cell Receptor DNA as a Biomarker of Clonally Expanded TILs in Breast Cancer after Immunotherapy.
Page DB; Yuan J; Redmond D; Wen YH; Durack JC; Emerson R; Solomon S; Dong Z; Wong P; Comstock C; Diab A; Sung J; Maybody M; Morris E; Brogi E; Morrow M; Sacchini V; Elemento O; Robins H; Patil S; Allison JP; Wolchok JD; Hudis C; Norton L; McArthur HL
Cancer Immunol Res; 2016 Oct; 4(10):835-844. PubMed ID: 27587469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
